AstraZeneca Annual Report and Form 20-F Information 2008

Consolidated Balance Sheet at 31 December

	Notes	2008 $m	2007 $m	2006 $m
Assets Non-current assets
Property, plant and equipment	7	7,043	8,298	7,453
Goodwill	8	9,874	9,884	1,097
Intangible assets	9	12,323	11,467	3,107
Other investments	10	156	182	119
Deferred tax assets	3	1,236	1,044	1,220
		30,632	30,875	12,996
Current assets Inventories	11	1,636	2,119	2,250
Trade and other receivables	12	7,261	6,668	5,561
Other investments	10	388	177	657
Income tax receivable		2,581	2,251	1,365
Cash and cash equivalents	13	4,286	5,867	7,103
		16,152	17,082	16,936
Total assets		46,784	47,957	29,932
Liabilities Current liabilities
Interest bearing loans and borrowings	14	(993)	(4,280)	(136)
Trade and other payables	17	(7,178)	(6,968)	(6,295)
Provisions	18	(600)	(387)	(39)
Income tax payable		(4,549)	(3,552)	(2,977)
		(13,320)	(15,187)	(9,447)
Non-current liabilities Interest bearing loans and borrowings	14	(10,855)	(10,876)	(1,087)
Deferred tax liabilities	3	(3,126)	(4,119)	(1,559)
Retirement benefit obligations	23	(2,732)	(1,998)	(1,842)
Provisions	18	(542)	(633)	(327)
Other payables	17	(149)	(229)	(254)
		(17,404)	(17,855)	(5,069)
Total liabilities		(30,724)	(33,042)	(14,516)
Net assets		16,060	14,915	15,416
Equity Capital and reserves attributable to equity holders of the Company
Share capital	20	362	364	383
Share premium account	19	2,046	1,888	1,671
Capital redemption reserve	19	94	91	71
Merger reserve	19	433	433	433
Other reserves	19	1,405	1,378	1,398
Retained earnings	19	11,572	10,624	11,348
		15,912	14,778	15,304
Minority equity interests	19	148	137	112
Total equity	19	16,060	14,915	15,416